ArticleCancers2022

Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System.

Emanuel Raschi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.